18-07-2019
102
Global Pediatric Influenza Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Most kids are enrolled in early education and child care programs. Seasonal influenza outbreaks are expected annually. Influenza can be severe, resulting in hospitalization or death of some children. Immunization against influenza is the best strategy to reduce infection and spread.

Scope of the Report:
The global Pediatric Influenza Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Pediatric Influenza Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Pediatric Influenza Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pediatric Influenza Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc.
NATCO Pharma Limited.
NESHER PHARMS
Johnson & Johnsons Inc.
Cipla
Hetero Pharma
Teva Pharmaceutical pvt. Ltd.
Olainfarm JSC
Gilead Sciences, Inc.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Antiviral Drug
Antipyretic
Neuraminidase inhibitor
Others

Market Segment by Applications, can be divided into
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Table of Contents

Global Pediatric Influenza Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024


Table of Contents

1 Pediatric Influenza Treatment Market Overview
1.1 Product Overview and Scope of Pediatric Influenza Treatment
1.2 Classification of Pediatric Influenza Treatment by Types
1.2.1 Global Pediatric Influenza Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Pediatric Influenza Treatment Revenue Market Share by Types in 2018
1.2.3 Antiviral Drug
1.2.4 Antipyretic
1.2.5 Neuraminidase inhibitor
1.2.6 Others
1.3 Global Pediatric Influenza Treatment Market by Application
1.3.1 Global Pediatric Influenza Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Pediatric Influenza Treatment Market by Regions
1.4.1 Global Pediatric Influenza Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Pediatric Influenza Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Pediatric Influenza Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pediatric Influenza Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Pediatric Influenza Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pediatric Influenza Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Pediatric Influenza Treatment (2014-2024)
2 Manufacturers Profiles
2.1 F. Hoffmann-La Roche Ltd
2.1.1 Business Overview
2.1.2 Pediatric Influenza Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 GlaxoSmithKline Plc.
2.2.1 Business Overview
2.2.2 Pediatric Influenza Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Plc. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 NATCO Pharma Limited.
2.3.1 Business Overview
2.3.2 Pediatric Influenza Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 NATCO Pharma Limited. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 NESHER PHARMS
2.4.1 Business Overview
2.4.2 Pediatric Influenza Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 NESHER PHARMS Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Johnson & Johnsons Inc.
2.5.1 Business Overview
2.5.2 Pediatric Influenza Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnsons Inc. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Cipla
2.6.1 Business Overview
2.6.2 Pediatric Influenza Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cipla Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Hetero Pharma
2.7.1 Business Overview
2.7.2 Pediatric Influenza Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Hetero Pharma Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Teva Pharmaceutical pvt. Ltd.
2.8.1 Business Overview
2.8.2 Pediatric Influenza Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Olainfarm JSC
2.9.1 Business Overview
2.9.2 Pediatric Influenza Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Olainfarm JSC Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Gilead Sciences, Inc.
2.10.1 Business Overview
2.10.2 Pediatric Influenza Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Gilead Sciences, Inc. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Pediatric Influenza Treatment Market Competition, by Players
3.1 Global Pediatric Influenza Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Pediatric Influenza Treatment Players Market Share
3.2.2 Top 10 Pediatric Influenza Treatment Players Market Share
3.3 Market Competition Trend
4 Global Pediatric Influenza Treatment Market Size by Regions
4.1 Global Pediatric Influenza Treatment Revenue and Market Share by Regions
4.2 North America Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
5 North America Pediatric Influenza Treatment Revenue by Countries
5.1 North America Pediatric Influenza Treatment Revenue by Countries (2014-2019)
5.2 USA Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
6 Europe Pediatric Influenza Treatment Revenue by Countries
6.1 Europe Pediatric Influenza Treatment Revenue by Countries (2014-2019)
6.2 Germany Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
6.4 France Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Pediatric Influenza Treatment Revenue by Countries
7.1 Asia-Pacific Pediatric Influenza Treatment Revenue by Countries (2014-2019)
7.2 China Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
7.5 India Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
8 South America Pediatric Influenza Treatment Revenue by Countries
8.1 South America Pediatric Influenza Treatment Revenue by Countries (2014-2019)
8.2 Brazil Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Pediatric Influenza Treatment by Countries
9.1 Middle East and Africa Pediatric Influenza Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
10 Global Pediatric Influenza Treatment Market Segment by Type
10.1 Global Pediatric Influenza Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Pediatric Influenza Treatment Market Forecast by Type (2019-2024)
10.3 Antiviral Drug Revenue Growth Rate (2014-2024)
10.4 Antipyretic Revenue Growth Rate (2014-2024)
10.5 Neuraminidase inhibitor Revenue Growth Rate (2014-2024)
10.6 Others Revenue Growth Rate (2014-2024)
11 Global Pediatric Influenza Treatment Market Segment by Application
11.1 Global Pediatric Influenza Treatment Revenue Market Share by Application (2014-2019)
11.2 Pediatric Influenza Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Ambulatory Surgical Centers Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Pediatric Influenza Treatment Market Size Forecast (2019-2024)
12.1 Global Pediatric Influenza Treatment Market Size Forecast (2019-2024)
12.2 Global Pediatric Influenza Treatment Market Forecast by Regions (2019-2024)
12.3 North America Pediatric Influenza Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Pediatric Influenza Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Pediatric Influenza Treatment Revenue Market Forecast (2019-2024)
12.6 South America Pediatric Influenza Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Pediatric Influenza Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Pediatric Influenza Treatment Picture
Table Product Specifications of Pediatric Influenza Treatment
Table Global Pediatric Influenza Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Pediatric Influenza Treatment Revenue Market Share by Types in 2018
Figure Antiviral Drug Picture
Figure Antipyretic Picture
Figure Neuraminidase inhibitor Picture
Figure Others Picture
Table Global Pediatric Influenza Treatment Revenue (Million USD) by Application (2014-2024)
Figure Pediatric Influenza Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Ambulatory Surgical Centers Picture
Figure Others Picture
Table Global Market Pediatric Influenza Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Pediatric Influenza Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Pediatric Influenza Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Pediatric Influenza Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Pediatric Influenza Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Pediatric Influenza Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Pediatric Influenza Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Type and Applications
Table F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Plc. Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Plc. Pediatric Influenza Treatment Type and Applications
Table GlaxoSmithKline Plc. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table NATCO Pharma Limited. Basic Information, Manufacturing Base and Competitors
Table NATCO Pharma Limited. Pediatric Influenza Treatment Type and Applications
Table NATCO Pharma Limited. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table NESHER PHARMS Basic Information, Manufacturing Base and Competitors
Table NESHER PHARMS Pediatric Influenza Treatment Type and Applications
Table NESHER PHARMS Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnsons Inc. Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnsons Inc. Pediatric Influenza Treatment Type and Applications
Table Johnson & Johnsons Inc. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Pediatric Influenza Treatment Type and Applications
Table Cipla Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Hetero Pharma Basic Information, Manufacturing Base and Competitors
Table Hetero Pharma Pediatric Influenza Treatment Type and Applications
Table Hetero Pharma Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Type and Applications
Table Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Olainfarm JSC Basic Information, Manufacturing Base and Competitors
Table Olainfarm JSC Pediatric Influenza Treatment Type and Applications
Table Olainfarm JSC Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences, Inc. Pediatric Influenza Treatment Type and Applications
Table Gilead Sciences, Inc. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Pediatric Influenza Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Pediatric Influenza Treatment Revenue Share by Players (2014-2019)
Figure Global Pediatric Influenza Treatment Revenue Share by Players in 2017
Figure Global Pediatric Influenza Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Pediatric Influenza Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Pediatric Influenza Treatment Revenue Market Share in 2018
Figure Global Pediatric Influenza Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Pediatric Influenza Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Pediatric Influenza Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Pediatric Influenza Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Pediatric Influenza Treatment Revenue Market Share by Regions in 2018
Figure North America Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure South America Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Table North America Pediatric Influenza Treatment Revenue by Countries (2014-2019)
Table North America Pediatric Influenza Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Pediatric Influenza Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Pediatric Influenza Treatment Revenue Market Share by Countries in 2018
Figure USA Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Table Europe Pediatric Influenza Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Pediatric Influenza Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Pediatric Influenza Treatment Revenue Market Share by Countries in 2018
Figure Germany Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure UK Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure France Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Pediatric Influenza Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Pediatric Influenza Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Pediatric Influenza Treatment Revenue Market Share by Countries in 2018
Figure China Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure India Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Table South America Pediatric Influenza Treatment Revenue by Countries (2014-2019)
Table South America Pediatric Influenza Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Pediatric Influenza Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Pediatric Influenza Treatment Revenue Market Share by Countries in 2018
Figure Brazil Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Pediatric Influenza Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Pediatric Influenza Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pediatric Influenza Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pediatric Influenza Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Pediatric Influenza Treatment Revenue and Growth Rate (2014-2019)
Table Global Pediatric Influenza Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Pediatric Influenza Treatment Revenue Share by Type (2014-2019)
Figure Global Pediatric Influenza Treatment Revenue Share by Type (2014-2019)
Figure Global Pediatric Influenza Treatment Revenue Share by Type in 2018
Table Global Pediatric Influenza Treatment Revenue Forecast by Type (2019-2024)
Figure Global Pediatric Influenza Treatment Market Share Forecast by Type (2019-2024)
Figure Global Antiviral Drug Revenue Growth Rate (2014-2019)
Figure Global Antipyretic Revenue Growth Rate (2014-2019)
Figure Global Neuraminidase inhibitor Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Pediatric Influenza Treatment Revenue by Application (2014-2019)
Table Global Pediatric Influenza Treatment Revenue Share by Application (2014-2019)
Figure Global Pediatric Influenza Treatment Revenue Share by Application (2014-2019)
Figure Global Pediatric Influenza Treatment Revenue Share by Application in 2018
Table Global Pediatric Influenza Treatment Revenue Forecast by Application (2019-2024)
Figure Global Pediatric Influenza Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Pediatric Influenza Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Pediatric Influenza Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Pediatric Influenza Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Pediatric Influenza Treatment Revenue Market Forecast (2019-2024)
Figure Europe Pediatric Influenza Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Pediatric Influenza Treatment Revenue Market Forecast (2019-2024)
Figure South America Pediatric Influenza Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Pediatric Influenza Treatment Revenue Market Forecast (2019-2024)

Enquiry Before Buying

*

*
*
*
*
*

Request Sample


*

*
*
*
*
*